MARCHETTI, Giovanna
 Distribuzione geografica
Continente #
NA - Nord America 12.074
AS - Asia 5.715
EU - Europa 3.568
SA - Sud America 965
AF - Africa 92
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.430
Nazione #
US - Stati Uniti d'America 11.822
SG - Singapore 2.306
CN - Cina 1.720
DE - Germania 861
BR - Brasile 823
UA - Ucraina 743
HK - Hong Kong 550
IT - Italia 453
TR - Turchia 436
GB - Regno Unito 384
VN - Vietnam 341
SE - Svezia 240
FI - Finlandia 217
RU - Federazione Russa 198
PL - Polonia 151
CA - Canada 122
MX - Messico 108
FR - Francia 73
IN - India 68
ID - Indonesia 64
AR - Argentina 54
JP - Giappone 51
NL - Olanda 50
BE - Belgio 47
ZA - Sudafrica 44
BD - Bangladesh 42
ES - Italia 37
CZ - Repubblica Ceca 33
EC - Ecuador 29
IQ - Iraq 24
LT - Lituania 17
MA - Marocco 15
AT - Austria 13
PY - Paraguay 13
UZ - Uzbekistan 13
CO - Colombia 12
IR - Iran 12
TW - Taiwan 11
IL - Israele 10
UY - Uruguay 10
CL - Cile 9
IE - Irlanda 9
SA - Arabia Saudita 9
VE - Venezuela 9
AU - Australia 8
KE - Kenya 8
PK - Pakistan 8
JO - Giordania 7
MY - Malesia 7
PT - Portogallo 7
CH - Svizzera 5
EG - Egitto 5
NP - Nepal 5
PE - Perù 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
CR - Costa Rica 4
DZ - Algeria 4
EU - Europa 4
JM - Giamaica 4
KZ - Kazakistan 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
GR - Grecia 3
HU - Ungheria 3
NZ - Nuova Zelanda 3
PA - Panama 3
RO - Romania 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
MT - Malta 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
PR - Porto Rico 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
IS - Islanda 1
KG - Kirghizistan 1
Totale 22.421
Città #
Singapore 1.313
Fairfield 1.044
Woodbridge 1.044
Ashburn 1.026
Chandler 780
Jacksonville 773
Houston 767
Ann Arbor 622
Santa Clara 594
Hong Kong 543
Beijing 528
Seattle 442
Wilmington 408
Cambridge 378
Dallas 331
Izmir 257
Nanjing 243
Munich 218
New York 199
Los Angeles 197
Boardman 179
Princeton 171
Warsaw 142
Ferrara 136
Ho Chi Minh City 119
The Dalles 110
San Diego 108
Buffalo 88
Milan 86
Mexico City 77
São Paulo 77
Shanghai 75
Nanchang 70
Shenyang 69
Dearborn 63
Hanoi 63
Bremen 62
Tianjin 59
Hebei 57
Turku 54
London 53
Hefei 52
Tokyo 46
Düsseldorf 45
San Mateo 45
Brussels 44
Jiaxing 44
Changsha 42
Jakarta 42
Toronto 39
Falkenstein 38
Falls Church 38
Montreal 37
Brooklyn 34
Council Bluffs 34
Orem 34
Jinan 33
Denver 31
Moscow 31
Chicago 30
Kunming 30
Frankfurt am Main 29
Addison 28
Chennai 28
Norwalk 28
Redwood City 28
Brno 27
Johannesburg 27
Rio de Janeiro 26
Belo Horizonte 25
San Jose 23
Auburn Hills 22
Helsinki 22
Rome 22
San Francisco 22
Stockholm 22
Amsterdam 21
Boston 21
Atlanta 20
Manchester 20
Zhengzhou 20
Des Moines 19
Mountain View 19
Guangzhou 18
Curitiba 17
Ningbo 16
Nuremberg 16
Augusta 15
Haiphong 15
Poplar 15
Biên Hòa 14
Hangzhou 14
Philadelphia 14
Porto Alegre 14
Washington 14
Florence 13
Phoenix 13
Dong Ket 12
Mcallen 12
Orange 12
Totale 15.157
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 292
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 280
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 242
Hemostasis biomarkers in multiple sclerosis 231
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 223
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 213
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 208
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 207
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 203
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 202
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 202
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 200
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 198
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 197
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 194
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 194
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 188
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 188
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 188
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 184
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 182
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 181
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 181
Membrane binding and anticoagulant properties of protein S natural variants 180
c-myc oncogene alterations in human thyroid carcinomas. 179
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 177
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 176
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 175
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 169
Plasma levels of soluble NCAM in multiple sclerosis 167
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 166
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 166
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 162
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 161
Factor VII mutant V154G models a zymogen-like form of factor VIIa 161
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 161
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 160
Partial gene deletion in a family with factor X deficiency 160
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 160
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 159
Taqi polymorphism at the human coagulation factor XII locus (F12) 158
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 157
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 157
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 157
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 157
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 156
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 156
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII 156
Molecular mechanisms of FVII deficiency: Expression of mutations clustered in the IVS7 donor splice site of factor VII gene 153
Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes 153
Modulation of factor VII levels by intron 7 polymorphisms: Population and in vitro studies 152
Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme 152
alpha-Thalassemia trait in the region of Ferrara. 151
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 148
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 148
Two additional TaqI RFLPs in von willebrand factor gene (VWF) and pseudogene 147
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 146
PRIMARY INTRAVASCULAR SYNOVIAL SARCOMA OF THE FEMORAL VEIN IN A MALE PATIENT, CASE REPORT 145
Two taqI RFLPs in the human von willebrand factor gene 144
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 143
Detection and characterization of polymorphic markers in the factor-VII gene. 142
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 141
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 140
CHROMOSOMAL LOCALIZATION AND CHARACTERIZATION OF RFLPs IN THE VON WILLEBRAND FACTOR PSEUDOGENE 139
The Gly331Ser mutation in factor VII in Europe and the Middle East 138
Symptomatic type II protein C deficiency caused by a missense mutation (Gly 381-->Ser) in the substrate-binding pocket 138
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 136
In-Frame Deletion of von Willebrand Factor Exons 26-34 (D3-A3 Domains) in Type II von Willebrand Disease. 136
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) 136
Angiotensin-converting enzyme gene polymorphism made risk of restenosis after coronary stenting 135
Study of a G/A variation in the 3' untranslated region of prothrombin mRNA in Italian patients with venous thrombosis 134
Calmodulin Is a Marker of a Distinct Smooth Muscle Cell Population Recruited by Plaque-Derived Macrophages from the Human Carotid Artery Media 134
Molecular genetics and biology of congenital hemorrhagic diseases 134
Sublocalization of von Willebrand Factor Pseudogene in 22q11.22-q11.23 and Detection of two TaqI RFLPs. 134
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 133
Risks factors for highly unstable response to oral anticoagulation: a case-control study 133
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 133
Caratterizzazione di una nuova mutazione nell’esone 28 del gene del fattore di von Willebrand (FvW) responsabile della malattia di vW di tipo IIA. 132
Localization of cloned human DNA sequences and analysis of chromosomal alteration by in situ hybridization 132
Clinical picture and management of congenital factor VII deficiency 131
PCR and specific oligonucleotide hybridization for the molecular characterization and carrier detection of hemophilia A. 131
Modulation of FVII levels by intron 7 polymorphisms: population and in vitro studies 130
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 130
Soluble neural cell adhesion molecule and behavioural recovery in minimally conscious patients undergoing transcranial direct current stimulation 130
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 127
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 127
Alterazione genica "de novo" in una variante della malattia di von Willebrand. 126
β+-thalassaemia in the Po river delta region (northern Italy): Genotype and β globin synthesis 125
null 125
Hyperhomocysteinemia and a common methylene-tetrahydrofolate reductase mutation (Ala223Val MTHFR) are not associated with a history of thrombosis in patients with inherited thrombophilia 125
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 124
Non-conventional therapeutic strategies for inherited disorders of hemostasis 124
Hemostasis gene expression of the internal jugular and saphenous veins 124
Identification of a c-myc oncogene lacking the exon 1 in the normal cells of a patient carrying a thyroid carcinoma 123
Decay of β-globin synthesis in heterozygous β 0 Ferrara thalassaemia 122
null 121
Oral contraceptives highlight the genotype-specific association between serum phospholipids and activated factor VII 121
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A 121
Modulation of thrombophilia genes by environmental factors 120
Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region 120
Totale 15.860
Categoria #
all - tutte 105.981
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 972
Totale 106.953


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.375 0 0 0 0 0 202 118 243 58 320 313 121
2021/20221.826 115 191 130 111 114 64 73 80 53 129 153 613
2022/20231.766 189 123 45 215 282 289 74 165 221 14 91 58
2023/2024924 69 91 34 32 64 191 20 62 23 20 24 294
2024/20253.496 93 66 295 99 468 299 78 173 507 479 536 403
2025/20265.826 974 410 1.066 1.331 1.495 550 0 0 0 0 0 0
Totale 22.637